Surrozen (SRZN) Non-Current Assets (2020 - 2026)

Surrozen (SRZN) recorded quarterly Non-Current Assets of $6.8 million in Q1 2026, down 5.68% quarter-over-quarter from $7.2 million in Q4 2025, and down 23.34% on a YoY basis from $8.8 million in Q1 2025.

Surrozen (SRZN) Non-Current Assets (2020 - 2026) Analysis & Trends

Surrozen's Non-Current Assets history runs 7 years deep, the most recent figure standing at $6.8 million for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 23.34% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $30.6 million (up 24.8% YoY), while the FY2025 annual figure was $7.2 million, down 24.83% from the prior year.
  • Non-Current Assets was $6.8 million for Q1 2026 at Surrozen, down from $7.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $22.0 million in Q1 2022 to a low of $2.7 million in Q3 2024.
  • Historically, Non-Current Assets has averaged $7.8 million across 5 years, with a median of $7.2 million in 2025.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets sank 89.89% in 2022, then soared 201.84% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $8.1 million in 2022, then plunged by 39.14% to $4.9 million in 2023, then jumped by 92.7% to $9.5 million in 2024, then retreated by 24.83% to $7.2 million in 2025, then dropped by 5.68% to $6.8 million in 2026.
  • The last three Non-Current Assets figures came in at $6.8 million (Q1 2026), $7.2 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 62,953.78
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - 289.41 Mn
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 4.56 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 486.60 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - 30.30 Mn
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 5.18 Mn
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 14.75 Bn
9 Abivax 94.37 Bn 94.37 Bn - 39.71 Mn
10 Surrozen 225,877.86 -106.68 Mn - 6.76 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.76 Mn
Dec 31, 2025 7.17 Mn
Sep 30, 2025 8.19 Mn
Jun 30, 2025 8.46 Mn
Mar 31, 2025 8.82 Mn
Dec 31, 2024 9.54 Mn
Sep 30, 2024 2.71 Mn
Jun 30, 2024 3.43 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 4.95 Mn
Sep 30, 2023 5.62 Mn
Jun 30, 2023 6.42 Mn
Mar 31, 2023 7.17 Mn
Dec 31, 2022 8.13 Mn
Sep 30, 2022 8.72 Mn
Jun 30, 2022 9.31 Mn
Mar 31, 2022 21.98 Mn
Dec 31, 2021 31.99 Mn
Sep 30, 2021 36.63 Mn
Jun 30, 2021 92.03 Mn